CN102631645B - Medicine for treating hyperplasia of mammary glands and ovarian cyst - Google Patents

Medicine for treating hyperplasia of mammary glands and ovarian cyst Download PDF

Info

Publication number
CN102631645B
CN102631645B CN2012101418186A CN201210141818A CN102631645B CN 102631645 B CN102631645 B CN 102631645B CN 2012101418186 A CN2012101418186 A CN 2012101418186A CN 201210141818 A CN201210141818 A CN 201210141818A CN 102631645 B CN102631645 B CN 102631645B
Authority
CN
China
Prior art keywords
parts
medicine
ovarian cyst
rhizoma
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2012101418186A
Other languages
Chinese (zh)
Other versions
CN102631645A (en
Inventor
王玫
张静
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012101418186A priority Critical patent/CN102631645B/en
Publication of CN102631645A publication Critical patent/CN102631645A/en
Application granted granted Critical
Publication of CN102631645B publication Critical patent/CN102631645B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a medicine for treating hyperplasia of mammary glands and ovarian cyst. The medicine is characterized by comprising the following raw materials by weight: 4-7 parts of herba leonuri, 1-3 parts of red ginseng, 2-5 parts of Radix Angelica Sinensis, 4-7 parts of Semen Coicis, 1-3 parts of Rhizoma Cyperi, 1-3 parts of Semen Vaccariae, 1-3 parts of Cornu Cervi Degelatinatum, 1-2 parts of frankincense, 1-2 parts of myrrh, 1-2 parts of Rhizoma Sparganii, 1-2 parts of Rhizoma curcumae, 1-3 parts of Panax pseudoginseng, 2-4 parts of snake gourd seed and 1-2 parts of liquorice. The medicine can be prepared into dosage forms which are provided according to pharmaceutics, such as capsules, tablets, granules, oral liquid and the like. The medicine has the functions of clearing heat and promoting diuresis, promoting blood circulation to remove blood stasis and removing swelling and stasis, and has good curative effects on treating hyperplasia of mammary glands and ovarian cyst, and other diseases.

Description

A kind of medicine for the treatment of cyclomastopathy, ovarian cyst
Technical field
The present invention relates to Chinese patent drug technique field, specifically a kind of medicine for the treatment of cyclomastopathy, ovarian cyst.
Background technology
Along with speeding of people's rhythm of life, the increase of operating pressure, numerous disease all is ascendant trend year by year.Women's diseases particularly, wherein the sickness rate of cyclomastopathy, ovarian cyst is for the highest.
Traditional Chinese medicine thinks that cyclomastopathy is that Chinese medicine is referred to as " nodules of the breast " because depressed rage impairing the liver, worry impairing spleen, qi stagnation blood stasis, expectorant congeal into due to core.Modern medicine is thought, its generation develops and lapses to, and is because the hormone cyclically-varying in human female causes fully.Too high when the estrogen level of ovarian secretion, the corpus luteum progestogen are very few, and perhaps the two secretion is inharmonious, just can cause breast duct epithelial cell and proliferation of fibrous tissue in breast, i.e. ovarian cyst etc.(as too nervous in work under the effect of body in some stressors, emotion is too exciting, advanced age is unmarried, not suckling in puerperal and suffer from some chronic disease etc.), just likely cause the cyclomastopathy tissue that breast should restore to can not get restoring or meromorphosis, in the course of time, just form cyclomastopathy.Show as the newborn leaf and the nodositas granule that thicken, the three large sings and symptomses such as distending pain of the breast and nipple galactorrhea.
Medicine and the method for existing treatment cyclomastopathy and ovarian cyst are more, but therapeutic effect is different, and have no the treatment cyclomastopathy identical with the present invention, medicine report and the commercially available prod of ovarian cyst.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of cyclomastopathy, ovarian cyst, its curative effect is rapid, and cure rate is high, and relapse rate is low.
The inventor constantly gropes in clinical through applying theory of Chinese medical science for many years, and the medicine for the treatment of cyclomastopathy, ovarian cyst is invented and summed up in experiment repeatedly, successful healing 10000 many cases cyclomastopathy patients, and curative effect is rapid, relapse rate is low.
The raw material weight proportioning of the medicine for the treatment of cyclomastopathy of the present invention, ovarian cyst is as follows:
Herba Leonuri 4~7, Radix Rubiae Yunnanensis 1~3, Radix Angelicae Sinensis 2~5, Semen Coicis 4~7, Rhizoma Cyperi 1~3, Semen Vaccariae 1~3, Cornu Cervi Degelatinatum 1~3, Olibanum 1~2, Myrrha 1~2, rhizoma sparganic 1~2, Rhizoma Curcumae 1~2, Radix Notoginseng 1~3, Semen Trichosanthis 2~4, Radix Glycyrrhizae 1~2.
Above-mentioned prescription is made included dosage form on existing pharmaceutics with existing method, as capsule, tablet, granule, oral liquid etc.
Instructions of taking: oral crude drug amount 5g once, every day three times.
Slight hypertrophy (0.5-1.0cm) is used 1-2 the course for the treatment of; Moderate hypertrophy (1.0-2.0cm) is used 3 courses for the treatment of; Severe hypertrophy (more than 2.0cm) is used 3-4 the course for the treatment of., more than 5 years, need to after disappearing, lump consolidate 2 courses for the treatment of for the course of disease.
Medicine of the present invention has clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling, the function of dispersing swelling and dissipating binds.Be used for the treatment of the diseases such as cyclomastopathy, ovarian cyst and have good curative effect.
The specific embodiment
Embodiment 1:
The composition by weight of raw material is (unit of weight: kilogram) Herba Leonuri 5, Radix Rubiae Yunnanensis 2, Radix Angelicae Sinensis 3, Semen Coicis 5, Rhizoma Cyperi 2, Semen Vaccariae 2, Cornu Cervi Degelatinatum 2, Olibanum 1, Myrrha 1, rhizoma sparganic 1, Rhizoma Curcumae 1, Radix Notoginseng 2, Semen Trichosanthis 3, Radix Glycyrrhizae 1.
Above-mentioned prescription is made capsule (, as medicine is raised concentrated solution with water extraction or alcohol, making capsule after drying) with existing method.
Embodiment 2:
The composition by weight of raw material is (unit of weight: kilogram) Herba Leonuri 4, Radix Rubiae Yunnanensis 1, Radix Angelicae Sinensis 2, Semen Coicis 4, Rhizoma Cyperi 1, Semen Vaccariae 1, Cornu Cervi Degelatinatum 1, Olibanum 1, Myrrha 1, rhizoma sparganic 1, Rhizoma Curcumae 1, Radix Notoginseng 1, Semen Trichosanthis 2, Radix Glycyrrhizae 1.
Above-mentioned prescription is made tablet with existing method.
Embodiment 3:
The composition by weight of raw material is (unit of weight: kilogram) Herba Leonuri 7, Radix Rubiae Yunnanensis 3, Radix Angelicae Sinensis 5, Semen Coicis 7, Rhizoma Cyperi 3, Semen Vaccariae 3, Cornu Cervi Degelatinatum 3, Olibanum 2, Myrrha 2, rhizoma sparganic 2, Rhizoma Curcumae 2, Radix Notoginseng 3, Semen Trichosanthis 4, Radix Glycyrrhizae 2.
With above-mentioned prescription with the agent of existing method granulation.
Clinical case efficacy analysis (300 example)
Diagnostic criteria:
(1) there is clinically the one or both sides breast single or multiple lumps to occur, most with the periodicity mastalgia, and many and emotion and menstrual cycle have obvious relation, general menstrual onset sx↑ about the last week, rear lump and the pain of passing through obviously alleviates, and continuous 3 months can not spontaneous remission.(2) get rid of the physiological mastalgia, as through front slight distending pain of the breast, adolescence mastalgia and mastalgia is only arranged and without the mastalgia of lump.(3) can touch the single or multiple irregular tuberositys that differ in size in clinical health check-up breast, matter is tough, and multidigit is in outside upper quadrant, and tuberosity and surrounding tissue, without adhesion, can be pushed, and slight tenderness is often arranged, and the axillary lymph knot is little.(4) utilize the auxiliary detection means such as mammography or xerography, B ultrasonic, thermal image figure, the lump pin of going is in case of necessity inhaled cytolgical examination and local living tissue pathologic finding, to get rid of other good, malignant galactophore diseases such as breast carcinoma, mammary gland fibroadenoma.
Clinical grading:
1. slight hypertrophy: the lump diameter is at 0.5-1.0cm;
2. moderate hypertrophy: lump diameter 1.0-2.0cm;
3. severe hypertrophy: the lump diameter is more than 2.0cm or be multiple.
Take the capsule by embodiment 1 prescription preparation.
Efficacy analysis:
Slight hypertrophy
Number of cases Clinical cure Produce effects Take a turn for the better Invalid
100 95 5 ? ?
The moderate hypertrophy
Number of cases Clinical cure Produce effects Take a turn for the better Invalid
100 90 5 4 1
The severe hypertrophy
Number of cases Clinical cure Produce effects Take a turn for the better Invalid
100 80 10 6 4
Sum up: clinical cure rate is that 90 effective percentage are 97%.
Model case is given an example:
1, Mrs Qiao, female 34 years old, address: Lijing,
2005 because mammary swelling, mastalgia, breast have lump, detects the bilateral breast hypertrophy, and color ultrasound shows in the 9-12 point of left side that direction can be visited and the about cystic mass of 2-2.5cm of a plurality of size, and 1-5 o'clock direction can be visited and a plurality of about 1.5-2.5 cystic mass.After through oral medicine of the present invention (embodiment 1), after 3 days, pain disappears, after 2 courses for the treatment of, symptom disappears fully.The color ultrasound detection display, lump disappears substantially.Consolidate again a course for the treatment of, so far not recurrence.
2, Mrs Zhou, female 32 years old, address: Lijiang City
Cyclomastopathy medical history 4 years, find original cyclomastopathy position in October, 2010, and lump strengthens, and through color ultrasound, shows lump 7.8cm.Once be breast carcinoma in Yunnan Cancer Hospital's tentative diagnosis,, by check pathological section, belonged to benign tumor, the suggestion operative treatment.Due to my occupational relation, do not want the treatment of performing an operation, medical in March, 2011, finding through diagnosis, is that the cyst that a plurality of cyclomastopathys form is piled up, through with Drug therapy of the present invention (embodiment 3) after 3 days, a plurality of lobule cysts, start to separate, after 2 courses for the treatment of, color ultrasound shows that a plurality of lumps diminish.Pass through again oral 2 courses for the treatment of, color ultrasound shows all disappearances, so far recurrence.
3, the Ms Zhang, Yulong county, Lijiang City, 48 years old address of female, ovarian cyst medical history 5 years, although all undesirable through the several different methods therapeutic effect, menoxenia appears recently, distending pain of the breast, detect and find the bilateral breast hypertrophy through Color B-Type Ultrasonic in BJ Union Hospital, the left ovary cyst, 4.8x4.7, hospital's suggestion operative treatment, because be away on official business, select again operative treatment after wanting to return, after take the treatment of medicine of the present invention (embodiment 1), go to again Beijing to go on business after two courses for the treatment of, surprised discovery ovarian cyst disappears, cyclomastopathy also is almost recovered, for consolidating curative effect, treat again a course for the treatment of, now fully recover.
4,30 years old address Lijing of Ms Zhang, before 2007 because of the left ovary cyst, the ovarian cyst Minimally Invasive Surgery of doing, hair follicle is swollen again to find left ovary in June, 2009, doctor advised excision left ovary, so carried out the left ovary excision.Found right ovary not only but also grown the cyst of a 4.6x5.3 in April, 2011, the doctor advises again excising right ovary, but as the women, and the Ms Zhang does not also bear child, marriage is challenged again, uses afterwards medicine of the present invention (embodiment 2), only three courses for the treatment of, show through Color B-Type Ultrasonic, ovarian cyst disappears fully., for preventing recurring oral two courses for the treatment of, do not send out so far.
Other similar sick columns example is cured, and repeats no more.

Claims (2)

1. medicine for the treatment of cyclomastopathy, ovarian cyst is characterized in that the parts by weight of raw materials proportioning of medicine is as follows:
Herba Leonuri 4~7, Radix Rubiae Yunnanensis 1~3, Radix Angelicae Sinensis 2~5, Semen Coicis 4~7, Rhizoma Cyperi 1~3, Semen Vaccariae 1~3, Cornu Cervi Degelatinatum 1~3, Olibanum 1~2, Myrrha 1~2, rhizoma sparganic 1~2, Rhizoma Curcumae 1~2, Radix Notoginseng 1~3, Semen Trichosanthis 2~4, Radix Glycyrrhizae 1~2.
2. the medicine for the treatment of cyclomastopathy according to claim 1, ovarian cyst is characterized in that the parts by weight of raw materials proportioning of medicine is as follows:
Herba Leonuri 5, Radix Rubiae Yunnanensis 2, Radix Angelicae Sinensis 3, Semen Coicis 5, Rhizoma Cyperi 2, Semen Vaccariae 2, Cornu Cervi Degelatinatum 2, Olibanum 1, Myrrha 1, rhizoma sparganic 1, Rhizoma Curcumae 1, Radix Notoginseng 2, Semen Trichosanthis 3, Radix Glycyrrhizae 1.
CN2012101418186A 2012-05-09 2012-05-09 Medicine for treating hyperplasia of mammary glands and ovarian cyst Expired - Fee Related CN102631645B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101418186A CN102631645B (en) 2012-05-09 2012-05-09 Medicine for treating hyperplasia of mammary glands and ovarian cyst

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101418186A CN102631645B (en) 2012-05-09 2012-05-09 Medicine for treating hyperplasia of mammary glands and ovarian cyst

Publications (2)

Publication Number Publication Date
CN102631645A CN102631645A (en) 2012-08-15
CN102631645B true CN102631645B (en) 2013-11-20

Family

ID=46616329

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101418186A Expired - Fee Related CN102631645B (en) 2012-05-09 2012-05-09 Medicine for treating hyperplasia of mammary glands and ovarian cyst

Country Status (1)

Country Link
CN (1) CN102631645B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103463276B (en) * 2013-08-06 2014-12-31 贵州铜仁梵康生物科技有限责任公司 Mammary gland hyperplasia treatment drug composition and preparation method thereof
CN106421645B (en) * 2016-10-19 2020-01-07 晋自俊 Medicine for treating hyperplasia of mammary glands and ovarian cyst

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101966322A (en) * 2010-07-13 2011-02-09 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof
CN101564521B (en) * 2009-05-20 2011-06-22 石振刚 External plaster for treating hyperplasia of mammary glands

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101564521B (en) * 2009-05-20 2011-06-22 石振刚 External plaster for treating hyperplasia of mammary glands
CN101966322A (en) * 2010-07-13 2011-02-09 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
乳腺增生病的中医药治疗概况;陈舒等;《浙江中医杂志》;20110228;第46卷(第02期);148-151 *
乳腺增生的中医药治疗进展;周莉娜;《中医药导报》;20101130;第16卷(第11期);112-114 *
周莉娜.乳腺增生的中医药治疗进展.《中医药导报》.2010,第16卷(第11期),
陈舒等.乳腺增生病的中医药治疗概况.《浙江中医杂志》.2011,第46卷(第02期),

Also Published As

Publication number Publication date
CN102631645A (en) 2012-08-15

Similar Documents

Publication Publication Date Title
CN102727832B (en) Chinese medicinal preparation for treating breast diseases and uterine fibroid and preparation method thereof
CN101116738A (en) Chinese traditional medicine for treating mammary gland hyperplasia and method for preparing the same
CN102120017B (en) Chinese medicinal preparation for treating uterus myoma
CN104523865A (en) Medicine for treating breast diseases
CN100398141C (en) Medicine for treating hyperplasia of mammary glands and preparation method thereof
CN102631453B (en) External medicament for treating hyperplasia of mammary glands and ovarian cyst
CN102671135B (en) Chinese medicinal composition for treating ovarian cyst, and preparation method thereof
CN102631645B (en) Medicine for treating hyperplasia of mammary glands and ovarian cyst
CN102988543B (en) Traditional Chinese medicine for treating hyperplasia of mammary glands and preparation method of traditional Chinese medicine
CN103989839A (en) Traditional Chinese medicine composition for treating acute mastitis and application thereof
CN101244175B (en) Chinese medicine emplastrum for treating gland hyperplasia
CN103156985B (en) Traditional Chinese medicine composition for treating cyclomastopathy
CN101979082B (en) Medicament for treating cyclomastopathy and preparation method and application thereof
CN102784361B (en) Traditional Chinese medicine composition for treating breast hyperplasia
CN102755515B (en) Traditional Chinese medicine decoction for treating hyperplasia of mammary glands
CN102319317B (en) Traditional Chinese medicine composition for treating menstrual disorder and preparation method thereof
CN102240302B (en) Chinese medicine composition of super gene active peptide
CN103599204B (en) Chinese medicine composition and its preparation method and application
CN101810687B (en) Medicament for treating hyperplasia of mammary glands and preparation method thereof
CN104623450A (en) Traditional Chinese medicine preparation for treating breast cancer
CN101396540B (en) Medicine composition for treating hyperplasia of mammary glands and preparation method thereof
CN104721647A (en) Pharmaceutical composition for treating cervical spondylosis
CN106994158B (en) Traditional Chinese medicine composition for treating ovarian cyst as well as preparation method and application thereof
CN104116924A (en) Traditional Chinese medicine composition as well as preparation method and application thereof
CN103479966A (en) Traditional Chinese preparation for treating prostatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131120

Termination date: 20200509